Sugi Predict

Sugi Predict / Compounds / SCHEMBL10116752

SCHEMBL10116752

SCHEMBL10116752

CCc1cc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)ccc1OC1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 9/20 0.47
▸ PDE4B Q07343 8/20 0.47
▸ PDE4C Q08493 8/20 0.47
▸ PDE4D Q08499 8/20 0.47
▸ PDE5A O76074 1/20 0.46
▸ PDE1A P54750 1/20 0.46
▸ PDE1B Q01064 1/20 0.46
▸ PDE1C Q14123 1/20 0.46
▸ MCHR1 Q99705 3/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ RORC P51449 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ P2RX4 Q99571 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10116435 0.86 PDE4D (0.47) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL10116661 0.82 LMNA (0.49) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10116718 0.82 F2 (0.58) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL11936143 0.82 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DPOLB
SCHEMBL10116688 0.81 LMNA (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL10116689 0.81 F2 (0.57) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL10114970 0.78 POLB (0.55) PDE4APOLBRORCALDH1A1LMNA
SCHEMBL10115496 0.78 ALDH1A1 (0.43) PDE4APDE4BPDE4CPDE4DHDAC1
SCHEMBL10116163 0.77 PDE4A (0.43) PDE4APDE4BPOLBRORC
SCHEMBL10116725 0.76 MAPT (0.43) PDE4AMCHR1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
EP-2014285-A1 NPYY5 antagonists Shionogi&Co., Ltd. (JP) 2009-01-14 — — EP disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R PDE4A 2689/4885PDE4B 2328/4885PDE4C 2121/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R PDE4A 2415/4885PDE4B 2069/4885PDE4C 1835/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R PDE4A 2664/4885PDE4B 2309/4885PDE4C 2101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.